We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$33.8B
AUM Growth
+$4.19B
Cap. Flow
+$264M
Cap. Flow %
0.78%
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$52.4M
2
TSLA icon
Tesla
TSLA
+$42.1M
3
MSFT icon
Microsoft
MSFT
+$16.9M
4
DIS icon
Walt Disney
DIS
+$14.5M
5
MS icon
Morgan Stanley
MS
+$11.9M

Top Sells

Rank Stock Value
1
UN
Unilever NV New York Registry Shares
UN
+$48.8M
2
T icon
AT&T
T
+$25.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$20M
4
AMZN icon
Amazon
AMZN
+$15.7M
5
BIIB icon
Biogen
BIIB
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Financials 13.6%
3 Healthcare 13.1%
4 Consumer Discretionary 11.54%
5 Communication Services 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRNE
2251
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$248K ﹤0.01%
36,362
-6,855
-16% -$55.1K
DT icon
2252
Dynatrace
DT
$12.4B
$246K ﹤0.01%
+5,691
New +$226K
KOD icon
2253
Kodiak Sciences
KOD
$2.65B
$246K ﹤0.01%
+1,676
New +$187K
VRRM icon
2254
Verra Mobility
VRRM
$626M
$246K ﹤0.01%
18,347
+4,005
+28% +$47.1K
CALX icon
2255
Calix
CALX
$2.39B
$244K ﹤0.01%
+8,190
New +$202K
DCOM
2256
DELISTED
Dime Community Bancshares
DCOM
$244K ﹤0.01%
15,490
-701
-4% -$9.79K
OMER icon
2257
Omeros
OMER
$690M
$243K ﹤0.01%
17,029
+2,559
+18% +$31.3K
XRN
2258
Chiron Real Estate Inc
XRN
$549M
$242K ﹤0.01%
3,713
+1,021
+38% +$70.3K
TAC icon
2259
TransAlta
TAC
$4.42B
$241K ﹤0.01%
31,739
-1,509
-5% -$10.1K
RCKT icon
2260
Rocket Pharmaceuticals
RCKT
$371M
$239K ﹤0.01%
+4,351
New +$159K
GWX icon
2261
State Street SPDR S&P International Small Cap ETF
GWX
$862M
$237K ﹤0.01%
6,704
MESO
2262
Mesoblast
MESO
$2.13B
$236K ﹤0.01%
13,912
-1,999
-13% -$49.2K
APLS
2263
DELISTED
Apellis Pharmaceuticals
APLS
$235K ﹤0.01%
+4,113
New +$174K
EBSB
2264
DELISTED
Meridian Bancorp, Inc.
EBSB
$235K ﹤0.01%
15,787
-679
-4% -$9.03K
CRVL icon
2265
CorVel
CRVL
$3.07B
$233K ﹤0.01%
+6,597
New +$205K
PGEN icon
2266
Precigen
PGEN
$1.96B
$233K ﹤0.01%
22,885
-4,084
-15% -$26.5K
XBIT icon
2267
XBiotech
XBIT
$68.3M
$233K ﹤0.01%
14,909
+2,967
+25% +$54.7K
LADR
2268
Ladder Capital
LADR
$1.26B
$232K ﹤0.01%
23,760
-2,199
-8% -$18.7K
RCUS icon
2269
Arcus Biosciences
RCUS
$3.71B
$231K ﹤0.01%
+8,909
New +$216K
GHG
2270
GreenTree Hospitality
GHG
$114M
$230K ﹤0.01%
17,201
+2,090
+14% +$27.5K
VCEL icon
2271
Vericel Corp
VCEL
$2.36B
$229K ﹤0.01%
+7,429
New +$177K
SHOE
2272
Shoe Station Group
SHOE
$396M
$228K ﹤0.01%
11,636
-504
-4% -$9.01K
SRCE icon
2273
1st Source
SRCE
$2.01B
$227K ﹤0.01%
5,635
-4,864
-46% -$178K
AKO.B icon
2274
Embotelladora Andina Series B
AKO.B
$4.64B
$226K ﹤0.01%
15,143
-2,795
-16% -$37.7K
STNG icon
2275
Scorpio Tankers
STNG
$3.96B
$225K ﹤0.01%
20,083
-3,896
-16% -$43.1K

Similar funds

Aperio Group's Q4 2020 Portfolio in Review

As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
  • Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
  • Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
  • Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
  • Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
  • Aperio Group opened 104 new positions and closed 53 in Q4 2020.
  • Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.